Cellectar Biosciences (CLRB) EBITDA (2010 - 2025)
Cellectar Biosciences (CLRB) EBITDA from Jun 30, 2010 to Dec 31, 2025. The TTM Cellectar Biosciences (CLRB) EBITDA is -$23M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Cellectar Biosciences (CLRB) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -17.21% |
| 3 Years TTM | -7.41% |
| 5 Years TTM | +8.49% |
| 10 Years TTM | +10.48% |
| All Time TTM | +12.72% |
Annual EBITDA change of Cellectar Biosciences (CLRB)
| Year | EBITDA | Change |
|---|---|---|
| 2025 | -$23M | -55.78% |
| 2024 | -$51M | +32.81% |
| 2023 | -$39M | +35.23% |
| 2022 | -$29M | +19.56% |
| 2021 | -$24M | +58.28% |
| 2020 | -$15M | +7.83% |
| 2019 | -$14M | +6.04% |
| 2018 | -$13M | +9.96% |
| 2017 | -$12M | +32.56% |
| 2016 | -$9.09M | +8.21% |
| 2015 | -$8.40M | -11.76% |
| 2014 | -$9.52M | -20.53% |
| 2013 | -$12M | +45.04% |
| 2012 | -$8.26M | +28.06% |
| 2011 | -$6.45M | +78.67% |
| 2010 | -$3.61M | -41.96% |
| 2009 | -$6.22M | +2.13% |
| 2008 | -$6.09M | +19.65% |
| 2007 | -$5.09M | +430.21% |
| 2006 | -$960K | +100.00% |
| 2005 | -$480K | +41.18% |
| 2004 | -$340K | +13.33% |
| 2003 | -$300K | N/A |
Comparison Cellectar Biosciences (CLRB) five years EBITDA CAGR with competitors
Cellectar Biosciences (CLRB) five years EBITDA CAGR is 9.00%.